Subsequently, we observed higher activity of the IL6‐JAK‐STAT3 pathway in TU212 and TU686 laryngeal cancer cells compared to normal laryngeal cells (Figure 5D). The gene discussed is IL6; the disease is laryngeal carcinoma.